[HTML][HTML] Development of Trypanosoma cruzi in vitro assays to identify compounds suitable for progression in Chagas' disease drug discovery
LM MacLean, J Thomas, MD Lewis… - PLoS neglected …, 2018 - journals.plos.org
Chagas' disease is responsible for significant mortality and morbidity in Latin America.
Current treatments display variable efficacy and have adverse side effects, hence more …
Current treatments display variable efficacy and have adverse side effects, hence more …
Development of Trypanosoma cruzi in vitro assays to identify compounds suitable for progression in Chagas' disease drug discovery
LM MacLean, J Thomas, MD Lewis… - PLoS Neglected …, 2018 - search.proquest.com
Chagas' disease is responsible for significant mortality and morbidity in Latin America.
Current treatments display variable efficacy and have adverse side effects, hence more …
Current treatments display variable efficacy and have adverse side effects, hence more …
Development of Trypanosoma cruzi in vitro assays to identify compounds suitable for progression in Chagas' disease drug discovery.
LM MacLean, J Thomas, MD Lewis… - PLoS Neglected …, 2018 - search.ebscohost.com
Chagas' disease is responsible for significant mortality and morbidity in Latin America.
Current treatments display variable efficacy and have adverse side effects, hence more …
Current treatments display variable efficacy and have adverse side effects, hence more …
Development of Trypanosoma cruzi in vitro assays to identify compounds suitable for progression in Chagas' disease drug discovery.
LM MacLean, J Thomas, MD Lewis, I Cotillo… - Plos Neglected …, 2018 - europepmc.org
Chagas' disease is responsible for significant mortality and morbidity in Latin America.
Current treatments display variable efficacy and have adverse side effects, hence more …
Current treatments display variable efficacy and have adverse side effects, hence more …
[HTML][HTML] Development of Trypanosoma cruzi in vitro assays to identify compounds suitable for progression in Chagas' disease drug discovery
LM MacLean, J Thomas, MD Lewis… - PLoS Neglected …, 2018 - ncbi.nlm.nih.gov
Chagas' disease is responsible for significant mortality and morbidity in Latin America.
Current treatments display variable efficacy and have adverse side effects, hence more …
Current treatments display variable efficacy and have adverse side effects, hence more …
[PDF][PDF] Development of Trypanosoma cruzi in vitro assays to identify compounds suitable for progression in Chagas' disease drug discovery
LM MacLean, J Thomas, MD Lewis… - … Negl Trop Dis, 2018 - pdfs.semanticscholar.org
Chagas' disease is responsible for significant mortality and morbidity in Latin America.
Current treatments display variable efficacy and have adverse side effects, hence more …
Current treatments display variable efficacy and have adverse side effects, hence more …
Development of Trypanosoma cruzi in vitro assays to identify compounds suitable for progression in Chagas' disease drug discovery
LM MacLean, J Thomas, MD Lewis… - PLoS neglected …, 2018 - pubmed.ncbi.nlm.nih.gov
Chagas' disease is responsible for significant mortality and morbidity in Latin America.
Current treatments display variable efficacy and have adverse side effects, hence more …
Current treatments display variable efficacy and have adverse side effects, hence more …
Development of Trypanosoma cruzi in vitro assays to identify compounds suitable for progression in Chagas' disease drug discovery
LM MacLean, J Thomas, MD Lewis, I Cotillo… - PLoS Neglected …, 2018 - go.gale.com
Chagas' disease is responsible for significant mortality and morbidity in Latin America.
Current treatments display variable efficacy and have adverse side effects, hence more …
Current treatments display variable efficacy and have adverse side effects, hence more …
[引用][C] Development of Trypanosoma cruzi in vitro assays to identify compounds suitable for progression in Chagas' disease drug discovery
LM MacLean, J Thomas, MD Lewis, I Cotillo… - PLOS Neglected …, 2018 - cir.nii.ac.jp
Development of Trypanosoma cruzi in vitro assays to identify compounds suitable for
progression in Chagas’ disease drug discovery | CiNii Research CiNii 国立情報学研究所 学術 …
progression in Chagas’ disease drug discovery | CiNii Research CiNii 国立情報学研究所 学術 …
[PDF][PDF] Development of Trypanosoma cruzi in vitro assays to identify compounds suitable for progression in Chagas' disease drug discovery
LM MacLean, J Thomas, MD Lewis, I Cotillo, DW Gray… - 2018 - core.ac.uk
Chagas' disease is responsible for significant mortality and morbidity in Latin America.
Current treatments display variable efficacy and have adverse side effects, hence more …
Current treatments display variable efficacy and have adverse side effects, hence more …